Azilsartan Medoxomil
NDC 52536-004, Azilsartan kamedoxomil, tablet, from Wilshire Pharmaceuticals, Inc..
- Product NDC
- 52536-004
- Status
- Listed
- Labeler
- Wilshire Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA200796
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52536-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZILSARTAN KAMEDOXOMIL40 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Decreased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52536-004-03 | 52536000403 | 30 TABLET in 1 BOTTLE (52536-004-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c09103d8-c094-473d-a303-bbb4f334aa8cNADAC price for package 52536000403
GET /v1/drugs/nadac/52536000403
Use it
Look up 52536-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52536-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52536-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.